YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Bone Biologics Corporation (BBLG [https://seekingalpha.com/symbol/BBLG]) announced it has entered into a definitive agreement with a single healthcare-focused institutional investor for an at-the-market private placement [https://seekingal…
BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics,” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced that it has entered…
BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today summarized key corporate, scie…
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT CIGL [https://www.chartmill.com/stock/quote/CIGL/profile] 91.84% CONCORDE INTERNATION-…
Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action! [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT OPEN [https://www.chartmill.com/stock/quote/OPEN/profile] 15.4% The tra…
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. [topmovers] GAINERS TICKER CHANGE COMMENT CIGL [https://www.char…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Zeta Network Group 120,949,328 3.4099 2.2201 2.629 +1.259 Opendoor Technol…
In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT CIGL [https://www.chartmill.com/stock/quote/CIGL/p…
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] GAINERS TICKER CHANGE COMMENT BRIA [https://www.chartmill.com/stock/quote/BRIA…
(RTTNews) - Bone Biologics Corporation (BBLG), a developer of orthobiologic products for spine fusion, has priced a public offering of 1,250,000 shares of common stock, Series D warrants, and Series E short-term warrants, each exercisable…
* Bone Biologics (NASDAQ:BBLG [https://seekingalpha.com/symbol/BBLG]) priced a public offering of 1.25M shares (or equivalents) at $4/share. * The offering includes Series D and Series E warrants to purchase up to 1.25M shares each. * Seri…
(RTTNews) - Bone Biologics (BBLG) announced the filing of a patent application with the United States Patent and Trademark Office for its NELL-1 protein. The patent application is directed to compositions of rhNELL-1 polypeptide and uses t…
* Bone Biologics (NASDAQ:BBLG [https://seekingalpha.com/symbol/BBLG]) announced it has regained compliance with Nasdaq concerning the $1 minimum bid price requirement. * BBLG met the requirement after its stock closed above $1 for 10 conse…
* Bone Biologics (NASDAQ:BBLG [https://seekingalpha.com/symbol/BBLG]) has filed to offer up to $35M in securities through a shelf registration. * The offering may include common stock, preferred stock, warrants, rights, or units in various…
(RTTNews) - Bone Biologics Corporation (BBLG) has announced a 1-for-6 reverse stock split of its common stock, which will take effect at 12:01 a.m. ET on Tuesday, June 10, 2025. The company's shares are expected to begin trading on a post-…
BURLINGTON, Mass., June 15, 2023--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets, today announced the pricing of an underwritte…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) recently announced that it has received approval to begin pilot clinical trials with NB1 in spinal fusion patients. The approval was given by…
BURLINGTON, Mass., June 06, 2023--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that a 1-for-30 reverse stock split became effective on June 5, 2023 an…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) recently announced that it has received approval to begin pilot clinical trials with NB1 in spinal fusion patients. The approval was given by…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) announced that it has received approval to begin pilot clinical trials with NB1 in spinal fusion patients. The approval was given by the Huma…
Company plans to begin 30-patient trial later this year BURLINGTON, Mass., April 11, 2023--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that the Human…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) continues to be a company that we are excited about as it pursues a way to improve the outcomes of spinal fusion surgery, while also having t…
BURLINGTON, Mass., January 26, 2023--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it has engaged Avania as the contract research organization (CRO) fo…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) is a medical device company focused on addressing the spinal fusion market with their worldwide exclusive use of the NELL-1 technology develo…
BURLINGTON, Mass., October 25, 2022--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today issued the following letter to stockholders from its President and Chief…
JERSEY CITY, N.J., Oct. 13, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services announced yesterday the closing of Bone Biologics (NASDAQ: BBLG) previously announced unde…
BURLINGTON, Mass., October 12, 2022--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced underwritten public of…
BURLINGTON, Mass., October 07, 2022--(BUSINESS WIRE)--Reissuing release to remove "million" after "$5,100,000" in the headline and first sentence of the text. The updated release reads: BONE BIOLOGICS PRICES $5,100,000 UNDERWRITTEN PUBLIC…
JERSEY CITY, N.J., Oct. 7, 2022 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiolog…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) is a company advancing a technology, known as NELL-1, that could positively impact millions of Americans suffering with back pain, and stands…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Although the stock (NASDAQ:BBLG) of Bone Biologics has suffered along with the rest of the biotech-related space, we remain confident in the company’s technology to impro…
BURLINGTON, Mass., March 23, 2022--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced that Jeffrey Frelick, the Company’s president and chief executiv…
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT In prior research reports we have expressed the importance we believed the partnership with the Musculoskeletal Transplant Foundation (MTF) was to Bone Biologics (NASDAQ:…
Secures rhNELL-1 Carrier for Bone Regeneration Spine Fusion Product BURLINGTON, Mass., March 07, 2022--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces it…
By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT There have been several reports out lately addressing the future of bone regeneration and the technologies surrounding it. We have read these reports and are excited abou…